SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022

    • Steady Operational Performance Amidst Macroeconomic Headwinds

      BOSTON and LAUSANNE, Switzerland, Aug. 09, 2022 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for the second quarter ended June 30, 2022.